Lanying Du

Lindsley F. Kimball Research Institute, New York Blood Center

Affiliated withNew York Blood Center New York Blood Center

Research Area

Biography

Lanying Du has not added Biography.
If you are Lanying Du and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 8	2011

Other Publications

Article	Year
Synthetic peptides outside the spike protein heptad repeat regions as potent inhibitors of SARS-associated coronavirus. Antiviral therapy\| PubMed ID: 15918330	2005
Identification and characterization of novel neutralizing epitopes in the receptor-binding domain of SARS-CoV spike protein: revealing the critical antigenic determinants in inactivated SARS... Vaccine\| PubMed ID: 16725238	2006
Recombinant adeno-associated virus expressing the receptor-binding domain of severe acute respiratory syndrome coronavirus S protein elicits neutralizing antibodies: Implication for developi... Virology\| PubMed ID: 16793110	2006
Severe acute respiratory syndrome-associated coronavirus 3a protein forms an ion channel and modulates virus release. Proceedings of the National Academy of Sciences of the United States of America\| PubMed ID: 16894145	2006
Receptor-binding domain of SARS-CoV spike protein induces long-term protective immunity in an animal model. Vaccine\| PubMed ID: 17092615	2007
Cleavage of spike protein of SARS coronavirus by protease factor Xa is associated with viral infectivity. Biochemical and biophysical research communications\| PubMed ID: 17533109	2007
Intranasal vaccination of recombinant adeno-associated virus encoding receptor-binding domain of severe acute respiratory syndrome coronavirus (SARS-CoV) spike protein induces strong mucosal... Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 18178835	2008
Priming with rAAV encoding RBD of SARS-CoV S protein and boosting with RBD-specific peptides for T cell epitopes elevated humoral and cellular immune responses against SARS-CoV infection. Vaccine\| PubMed ID: 18289745	2008
Development of subunit vaccines against severe acute respiratory syndrome. Drugs of today (Barcelona, Spain : 1998)\| PubMed ID: 18301805	2008
Evaluation of recombinant Onchocerca volvulus activation associated protein-1 (ASP-1) as a potent Th1-biased adjuvant with a panel of protein or peptide-based antigens and commercial inactiv... Vaccine\| PubMed ID: 18675867	2008
The spike protein of SARS-CoV--a target for vaccine and therapeutic development. Nature reviews. Microbiology\| PubMed ID: 19198616	2009
Antigenicity and immunogenicity of SARS-CoV S protein receptor-binding domain stably expressed in CHO cells. Biochemical and biophysical research communications\| PubMed ID: 19422787	2009
Recombinant receptor-binding domain of SARS-CoV spike protein expressed in mammalian, insect and E. coli cells elicits potent neutralizing antibody and protective immunity. Virology\| PubMed ID: 19683779	2009
Research and development of universal influenza vaccines. Microbes and infection / Institut Pasteur\| PubMed ID: 20079871	2010
An M2e-based multiple antigenic peptide vaccine protects mice from lethal challenge with divergent H5N1 influenza viruses. Virology journal\| PubMed ID: 20082709	2010
A 219-mer CHO-expressing receptor-binding domain of SARS-CoV S protein induces potent immune responses and protective immunity. Viral immunology\| PubMed ID: 20374001	2010
Development of a safe and convenient neutralization assay for rapid screening of influenza HA-specific neutralizing monoclonal antibodies. Biochemical and biophysical research communications\| PubMed ID: 20617558	2010
An H5N1 M2e-based multiple antigenic peptide vaccine confers heterosubtypic protection from lethal infection with pandemic 2009 H1N1 virus. Virology journal\| PubMed ID: 20624292	2010
Development of a safe and convenient neutralization assay for rapid screening of influenza HA-specific neutralizing monoclonal antibodies. Biochemical and biophysical research communications\| PubMed ID: 20685351	2010
Induction of protection against divergent H5N1 influenza viruses using a recombinant fusion protein linking influenza M2e to Onchocerca volvulus activation associated protein-1 (ASP-1) adjuv... Vaccine\| PubMed ID: 20732469	2010
Potent and persistent antibody responses against the receptor-binding domain of SARS-CoV spike protein in recovered patients. Virology journal\| PubMed ID: 21047436	2010
Roles of the hemagglutinin of influenza A virus in viral entry and development of antiviral therapeutics and vaccines. Protein & cell\| PubMed ID: 21203946	2010
A recombinant vaccine of H5N1 HA1 fused with foldon and human IgG Fc induced complete cross-clade protection against divergent H5N1 viruses. PloS one\| PubMed ID: 21304591	2011
Complement inhibition alleviates paraquat-induced acute lung injury. American journal of respiratory cell and molecular biology\| PubMed ID: 21421909	2011
CL-385319 inhibits H5N1 avian influenza A virus infection by blocking viral entry. European journal of pharmacology\| PubMed ID: 21536025	2011